Concepedia

Felix F. Lillich

FF

Statistics

Publications

6

Citations

175

H-Index

6

Active since

2016

Affiliations

Goethe University Frankfurt(Current)

Fraunhofer Institute for Translational Medicine and Pharmacology

Felix F. Lillich is an author at Goethe University Frankfurt specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2016–2024

6

Publications

6

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

Jan S. Kramer, Stefano Woltersdorf, Thomas Duflot et al. · Journal of Medicinal Chemistry · 2019 · 46 citations · Full text

, , +17

Automated design of multi-target ligands by generative deep learning

Laura Isigkeit, Tim Hörmann, Espen Schallmayer et al. · Nature Communications · 2024 · 41 citations · Full text

, , +16

Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics

Simone Schierle, A. Chaikuad, Felix F. Lillich et al. · Journal of Medicinal Chemistry · 2021 · 29 citations · Full text

, , +17

Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors

Felix F. Lillich, Sabine Willems, Xiaomin Ni et al. · Journal of Medicinal Chemistry · 2021 · 28 citations · Full text

, , +17

DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells

Sandra Seredinski, Frederike Boos, Stefan Günther et al. · Molecular Therapy — Nucleic Acids · 2022 · 21 citations · Full text

, , +17

1–5 of 6